InflaRx (IFRX) Capital Expenditures (2020 - 2026)

InflaRx has disclosed Capital Expenditures across 7 years of filings, most recently posting -$11083.4 for Q1 2026.

• Capital Expenditures for Q1 2026 came in at -$11083.4, down 0.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $135796.7 (up 141.98% YoY), and the FY2025 annual result was $134672.9, up 168.88% from the prior year.
• Capital Expenditures came in at -$11083.4 for Q1 2026 at InflaRx, down from $266960.6 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $266960.6 in Q4 2025 to a low of -$147408.4 in Q4 2022.
• The 5-year median for Capital Expenditures is -$10988.0 (2025), against an average of $5573.7.
• Peak annual rise in Capital Expenditures reached 225.02% in 2025, while the deepest fall reached 5467.55% in 2025.
• InflaRx's Capital Expenditures stood at -$147408.4 in 2022, then jumped by 192.73% to $136689.6 in 2023, then sank by 39.91% to $82135.4 in 2024, then soared by 225.02% to $266960.6 in 2025, then plunged by 104.15% to -$11083.4 in 2026.
• The last three Capital Expenditures figures came in at -$11083.4 (Q1 2026), $266960.6 (Q4 2025), and -$102844.1 (Q3 2025), per Business Quant data.